Phentolamine Mesilate/CAS 65-28-1/Pharmaceutical

Phentolamine Mesilate (CAS 65-28-1) is a high-purity pharmaceutical API classified as a potent alpha-adrenergic blocker, featuring a stable molecular structure that ensures reliable pharmacological activity. Its core mechanism lies in competitively blocking alpha-1 and alpha-2 receptors, effectively dilating peripheral blood vessels, reducing vascular resistance, and improving blood circulation. Unlike generic blockers, this premium-grade API exhibits excellent solubility in water, enabling seamless integration into various pharmaceutical formulations such as injections and tablets, with minimal side effects for clinical applications.

This versatile API caters to the critical needs of pharmaceutical manufacturers, research institutions, and clinical suppliers. It is widely applied in treating hypertensive emergencies, preventing tissue necrosis caused by norepinephrine extravasation, and assisting in the diagnosis of pheochromocytoma. Produced under strict GMP standards, each batch undergoes rigorous purity testing to guarantee consistent performance and compliance with international pharmaceutical regulations. For businesses prioritizing safety, efficacy, and regulatory compliance, this Phentolamine Mesilate API serves as an indispensable raw material for developing high-quality cardiovascular and clinical emergency drugs.